Abacavir sulfate
Abacavir sulfate is a pharmaceutical drug with 56 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 49 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
18
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
96.1%
49 of 51 finished
3.9%
2 ended early
0
trials recruiting
56
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
Clinical Trials (56)
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment
Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment
A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication
A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
Blood Levels of Abacavir in HIV Infected Adolescents
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 56